News | Pacemakers | May 09, 2016

Pacemaker Patients With Sleep Apnea at Increased Risk of Atrial Fibrillation

First-ever results show link between pacemaker-detected sleep apnea and atrial fibrillation

May 9, 2016 — Results from a first-of-its-kind study identify a significant increase in the incidence of atrial fibrillation (AF) among patients with pacemaker-detected sleep apnea. The study suggests that monitoring for sleep apnea in patients with pacemakers is imperative in identifying patients’ risk for developing AF. The study was presented at Heart Rhythm 2016, the Heart Rhythm Society’s 37th Annual Scientific Sessions, May 4-7 in San Francisco.

Sleep apnea is a common condition in which breathing stops or becomes critically shallow during sleep. It is associated with cardiovascular diseases and is highly prevalent in patients with pacemakers. While it is understood that sleep apnea is a risk factor for AF, the risk of AF for pacemaker patients with sleep apnea is largely unknown.

The study enrolled a total of 150 patients with atrio-ventricular block or sick sinus syndrome who underwent implantation of a dual-chamber pacemaker. The patients were monitored for sleep apnea events during the first week after the device was implanted. The severity of sleep apnea in patients was determined by the pacemakers’ ApneaScan algorithm (Boston Scientific), which automatically detects sleep apnea events. Sleep apnea was defined as severe if a patient had 30 or more events per hour for at least one night. If the device detected arrhythmias for more than one hour in a day, patients were considered to have experienced AF episodes.

During an eight-month follow-up, AF occurred in 36 percent of patients and, specifically, in 25 (28 percent) out of the 89 patients who had no history of the arrhythmia. Severe sleep apnea was detected in 85 patients, 56 of whom had no history of AF. In presence of severe sleep apnea, the risk of AF was three-fold higher in the overall population, and approximately six-fold higher among those with no previous history of AF.

“In recent years, pacemakers have increasingly become equipped with sleep apnea monitoring measures, and in using these tools, we were able to identify how pacemaker patients with sleep apnea are at risk for developing atrial fibrillation,” said Andrea Mazza, M.D., Santa Maria della Stella Hospital. “Our results are the first to show that patients with pacemakers and sleep apnea are at a higher risk of developing atrial fibrillation. Now that we understand the connection, it’s important that patients and doctors, collectively, are more diligent about monitoring for sleep apnea in order to engage in solutions that may prevent the development of atrial fibrillation and, possibly, thromboembolic complications.”

Study authors note that a high prevalence of sleep apnea in patients with pacemakers requires a more defined approach to diagnosis in order to explore potential therapeutic targets for reducing occurrence and recurrence of AF.

For more information: www.hrsonline.org

Related Content

An screen shot of the Abbott Focal Impulse and Rotor Modulated (FIRM)-guided ablation system used to guide AF ablation procedures.

An screen shot of the Abbott Focal Impulse and Rotor Modulated (FIRM)-guided ablation system used to guide AF ablation procedures. 

News | Atrial Fibrillation | May 14, 2019 | Dave Fornell, Editor
May 14, 2019 – The first prospective, multicenter, randomized, controlled trial to compare conventional pulmonary vei
The Parasym Salustim device ear clip stimulates the vagus nerve, which was found to reduced AF burden compared with a sham procedure in the TREAT AF trial.

The Parasym Salustim device ear clip stimulates the vagus nerve, which was found to reduced AF burden compared with a sham procedure in the TREAT AF trial. 

News | Atrial Fibrillation | May 13, 2019
May 13, 2019 — A randomized clinical trial effectively used nerve stimulation through an ear clip to reduce...
More than 60,000 from the general population in Belgium were screened for AFib using only a smartphone app in the DIGITAL-AF II study. The study used the FibriCheck app found 791 participants has measurements indicative for AF.

More than 60,000 from the general population in Belgium were screened for AFib using only a smartphone app in the DIGITAL-AF II study. The study used the FibriCheck app found 791 participants has measurements indicative for AF.

News | Atrial Fibrillation | May 13, 2019
May 13, 2019 — A digital screening for...
Rivaroxaban is among four new oral anticoagulants (NOAC) now recommended by atrial fibrillation guidelines over the old standard of warfarin.

Rivaroxaban is among four new oral anticoagulants (NOAC) now recommended by atrial fibrillation guidelines over the old standard of warfarin.

 

Feature | Atrial Fibrillation | January 30, 2019
January 30, 2019 — Updated atrial fibrillation (AFib) treatment guidelines released this week now recommend new oral
Aurigen Medical Atrial Fibrillation Device Wins ICI Innovation Award
News | Atrial Fibrillation | December 18, 2018
Irish medical device company AuriGen Medical won the prestigious Global Innovation Award at the International...

An example of the new generation of cardiac monitoring device that is replacing Holter monitoring is the Cardea Solo wearable sensor. The FDA-cleared device automatically analyzes data when the device is turned back into the physician's office and automatically produces a draft summary report. This technology can simplify the workflow by eliminating the need for third-party involvement.

Feature | Atrial Fibrillation | September 13, 2018
Rapid advances in technology to monitor atrial fibrillation (AF or Afib) are enabling clinicians to access real-time
Atrial Fibrillation Patients Diagnosed With Carotid Atery Disease Face Increased Risk of Dementia

Image courtesy of Intermountain Medical Center Heart Institute

News | Atrial Fibrillation | May 24, 2018
Atrial fibrillation patients who are diagnosed with carotid artery disease face higher risks for developing dementia,...
Overlay Init